ORTEXORTEX News
Tracking RF? Get live short interest, options flow, and signals on ORTEX.Sign up free →
RF
Trader NoteRF

RF Earnings Are In: Shorts Hold, Analysts Trim, Stock Rebounds

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 3 min readdata as of 21 Oct 2026, 22:02

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Regions Financial has printed its Q3 results and the market reaction tells a story of relief rather than conviction, with the stock up 3.1% on the week to $27.85 but short sellers showing little urgency to cover.

The pre-earnings short buildup chronicled in the October 13 note has largely held in place. Short interest slipped just 0.4% on October 20 to 62.7 million shares, or 7.1% of the free float, still well above the 55.7 million shares noted two weeks ago. The month-on-month increase remains near 13%. Borrow conditions give shorts no reason to rush: cost to borrow has eased to 0.49%, down about 4% on the week, and availability is ample at 757% of short interest outstanding, far above the 52-week low of 533%. There is no mechanical squeeze pressure in the lending market. Options positioning has come off the October 7 peak of 1.47 but the put/call ratio at 1.40 remains elevated relative to mid-September levels around 1.08, broadly in line with the 20-day average of 1.38. The defensiveness has faded at the margin but has not unwound.

The analyst community moved in one direction after the print: trimming targets, while keeping ratings intact. Citigroup lowered its target from $36 to $32 yesterday, maintaining Buy. RBC Capital cut from $34 to $32, holding Outperform. Cantor Fitzgerald stood pat at $32 with a reiterated Overweight. On the more cautious end, Truist Securities and Stephens both lowered targets to $30, each maintaining Hold and Equal-Weight respectively. JPMorgan and UBS, both at Neutral, had already cut to $30.50 and $30 ahead of the print. The consensus mean target now stands at $31.14, roughly 12% above the current price, and the consensus rating remains Buy. The valuation picture is undemanding: the stock trades at about 9.9x earnings and 1.3x book, with the price-to-book ratio up modestly over the past week as the stock recovered. The factor score on analyst recommendation divergence ranks in the 90th percentile, suggesting the Street's constructive lean is unusually firm relative to the broader universe.

The bull and bear cases are now clearly defined by the print itself. Bulls point to genuine credit quality improvement: net charge-offs fell to 29 basis points of average loans in Q3, nonperforming loans dropped to $585 million (0.59% of loans), net interest income rose to $1.298 billion, and the net interest margin expanded to 3.68%. Record Capital Markets revenue and a likely record year in Wealth Management reinforce the earnings durability argument. Bears focus on what comes next: management cut the 2027 net interest income forecast to $5.354 billion, loan growth has slowed, deposits fell 1.2% quarter-on-quarter, and accumulated other comprehensive income losses widened to $3.197 billion, pushing tangible book value down 8.2% in the quarter to $12.65. The stock's short score of 53.1 sits in the 9th percentile for short positioning relative to the broader universe, a reminder that even with 7% of the float short, the position is not extreme in a sector context.

The FDIC call reports tracked by ORTEX Alt Data showed record Q2 total assets of $159.8 billion and record Q2 net loans and leases of $98.3 billion for the bank's insured charters, the largest second quarter for both series since the dataset began in 2024. The series has not yet been tested as a leading indicator for Regions' reported figures, so these readings are balance-sheet colour rather than a signal for the Q3 print already delivered.

Among closely correlated peers, the post-earnings bounce was broad. KEY led the group with a 4.5% weekly gain, FITB rose 4.4%, and ZION added 3.8%. RF at 3.1% tracked in the middle of the pack, with MTB lagging at just 0.2% for the week, suggesting the sector-wide relief rally was more uniform than stock-specific.

With Q3 now behind it and the next earnings event pencilled in for January 22, the question for the weeks ahead is whether the short interest built up in anticipation of the print begins to unwind or whether the 2027 NII guidance cut keeps bears engaged at current levels.

Stocks in this article

See the live data behind this article on ORTEX.

Open RF on ORTEX →

How this article was generated

Generated
21 Oct 2026, 22:03
Data as of
21 Oct 2026, 22:02
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.